AstraZeneca ditches plan to build new UK vaccine plant

Open the Editor’s Marking Free

Rulla Khalaf, the FT editor, chooses its preferred stories in this week’s news.

Astrazeneca is withdrawal of 450 million Pounds of Vaccine Production Plant for British Officials on Breast Processes for British Officers for Weeks.

Officials have submitted a revised proposal for the site in Speke this month, which was significantly higher than 40 million pounds offered last year, they said people with the knowledge of the agreements.

Last summer, the steral government searched for the state support for the project to cut down from about 90 million pounds to 40 million pounds, according to the people who presented.

“After the delayed discussions with the government, we no longer pursue our programmed contribution to Speke,” said Astreachena on Friday. “Several factors have affected this decision, including the deadline for the final proposal compared to the previous government proposal.”

According to the company, the existing SPEKE website will continue to produce and supply the flu vaccine.

Former Protective Chancellor Jeremer Heremy Hunt’s previous offer to up to 70 million grants to develop existing Astrazeneca The vaccine in Speke, as well as the support and development of the British Health Safety Agency, 20 meters, the people reported.

The treasury did not immediately respond to the comment.

People close to the pharmaceutical company say it looks at other possible production websites.

The largest British capitalization of Britain has become a “deeply disappointed” with another person, with another person, in connection with protest prices and the future of life.

In November, she said she was planned to invest $ 3.5 billion in the United States, the world’s largest pharmaceutical market research and development, which generates 44 percent of the company’s sales.

Astrazeneca’s chief executive Pascal Sorot said that investments reflect the “Attraction of Business Environment with the quality of talent and innovative opportunities.”

The company also plans to produce $ 1.5 billion in Singapore, and last week, 560 million investments in Canada.

There is no suggestion that his decision on Speke Facility will affect any other investments in AstrAzeneca in the UK, people with knowledge of business report.

In March, the British Conservative Government said that she would invest as a astrenic of the research, development and production of new vaccines at Speke.

Financial times when the company wanted to provide up to 100 million pounds.